AAIS
MRNA icon

ABN AMRO Investment Solutions’s Moderna MRNA Stock Holding History

ABN AMRO Investment Solutions’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,467
Closed -$227K – 450
2024
Q4 		$227K Buy
5,467
+1,774
+48% +$84.8K ﹤0.01% 430
2024
Q3 		$247K Sell
3,693
-602
-14% -$55.3K ﹤0.01% 456
2024
Q2 		$510K Buy
+4,295
New +$544K 0.01% 399
2023
Q2 		– Sell
-1,395
Closed -$214K – 420
2023
Q1 		$214K Buy
+1,395
New +$230K ﹤0.01% 402

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ABN AMRO Investment Solutions's MRNA Position: Q1 2025 in Review

ABN AMRO Investment Solutions sold out of Moderna (MRNA) in Q1 2025, closing a stake of 5,467 shares — an estimated $227K sold.

ABN AMRO Investment Solutions first reported a position in MRNA in Q1 2023 and held it in 4 quarters. The position peaked at $510K in Q2 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • ABN AMRO Investment Solutions reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • ABN AMRO Investment Solutions sold 5,467 Moderna shares in Q1 2025, an estimated $227K.
  • ABN AMRO Investment Solutions first reported a position in Moderna in Q1 2023 and held it in 4 quarters.
  • ABN AMRO Investment Solutions's Moderna position peaked at $510K in Q2 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on ABN AMRO Investment Solutions's 13F filing for Q1 2025, filed 27 Aug 2025.